Pedro Luis
Sánchez Fernández
Catedrático de Universidad
Hospital Universitario La Fe
Valencia, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario La Fe (19)
2023
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
2022
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
2021
-
A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure
Frontiers in Physiology, Vol. 12
2020
2019
-
Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity
Journal of the American College of Cardiology, Vol. 73, Núm. 7, pp. 779-791
2017
-
Dynamic edematous response of the human heart to myocardial infarction: Implications for assessing myocardial area at risk and salvage
Circulation, Vol. 136, Núm. 14, pp. 1288-1300
2016
-
Comparison of 1-Year Outcome in Patients with Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)
American Journal of Cardiology, Vol. 118, Núm. 2, pp. 244-250
2009
-
Patient registries of acute coronary syndrome assessing or biasing the clinical real world data?
Circulation: Cardiovascular Quality and Outcomes, Vol. 2, Núm. 6, pp. 540-547
1995
-
Chronic rejection in 500 kidney transplant patients treated with cyclosporine: Incidence and risk factors
Transplantation Proceedings
1994
-
Analysis of the risk factors of late failure in renal transplantation under cyclosporine immunosuppression
Transplantation Proceedings
-
INSUFICIENCIA RENAL AGUDA TRAS LA ADMINISTRACION DE ENALAPRIL COMO FORMA DE PRESENTACION DE LA ARTERITIS DE TAKAYASU
Medicina Clinica, Vol. 102, Núm. 2, pp. 60-63
-
Interaction between probucol and cyclosporine in renal transplant patients
Annals of Pharmacotherapy, Vol. 28, Núm. 7-8, pp. 940-943
-
M. kansasii infection of the lung after cytomegalovirus pneumonia in a kidney transplant patient
Archivos de Bronconeumologia, Vol. 30, Núm. 4, pp. 222-225
1992
-
Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation
Transplantation Proceedings
-
Five-year experience with a triple drug protocol in renal transplantation
Transplantation Proceedings
-
Risk factors and prognostic significance of hypertension after renal transplantation
Transplantation Proceedings
-
Six-year experience with a triple drug protocol in renal transplantation: Analysis of risk factors
Transplantation Proceedings
-
Triple drug maintenance therapy in renal transplantation
Transplantation Proceedings
1991
-
INFLUENCIA DE LA EDAD DEL DONANTE SOBRE LA FUNCION DEL INJERTO Y LA SUPERVIVENCIA DEL TRASPLANTE RENAL
Nefrologia, Vol. 11, Núm. SUPPL. 1, pp. 127-132